Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("KREUTZ F")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 20 of 20

  • Page / 1

Export

Selection :

  • and

OPTIMAL HEMATOCRIT FOR CANINE SKELETAL MUSCLE DURING RHYTHMIC ISOTONIC EXERCISEGAEHTGENS P; KREUTZ F; ALBRECHT KH et al.1979; EUROP. J. APPL. PHYSIOL. OCCUP. PHYSIOL.; DEU; DA. 1979; VOL. 41; NO 1; PP. 27-39; BIBL. 36 REF.Article

TRITIUMGEWINNUNG AUS ZIRCALOYHUELLROHREN ABGEBRANNTER LWR-BRENNELEMENTE = TRITIUM RECOVERY FROM ZIRCALOY CLADDING HULLS OF LWR SPENT FUEL ELEMENTS = RECUPERATION DE TRITIUM DES TUBES DE GAINAGE EN ZIRCALOY DES ELEMENTS COMBUSTIBLES IRRADIES DES REACTEURS A EAU LEGEREMUELLER B; KREUTZ F; KROTH K et al.1981; BER. KERNFORSCHUNGSANL. JUELICH; ISSN 0366-0885; DEU; DA. 1981; NO 1715; PP. 1-36; ABS. ENG; BIBL. 2 P.Serial Issue

FAHRAEUS EFFECT AND CELL SCREENING DURING TUBE FLOW OF HUMAN BLOOD. II. EFFECT OF DEXTRAN-INDUCED CELL AGGREGATIONGAEHTGENS P; KREUTZ F; ALBRECHT KH et al.1978; BIORHEOLOGY; GBR; DA. 1978; VOL. 15; NO 3-4; PP. 155-161; BIBL. 12 REF.Article

FAHRAEUS EFFECT AND CELL SCREENING DURING TUBE FLOW OF HUMAN BLOOD. I. EFFECT OF VARIATION OF FLOW RATEGAEHTGENS F; ALBRECHT KH; KREUTZ F et al.1978; BIORHEOLOGY; GBR; DA. 1978; VOL. 15; NO 3-4; PP. 147-154; BIBL. 27 REF.Article

UEBER DAS VERHALTEN DER RUHE- UND BELASTUNGS-AUSWURFFRAKTION (EF) BEI HERZINFARKTPATIENTEN VOR UND NACH VIERWOECHIGEM TRAITING. VERGLEICH ZU EINER KONTROLLGRUPPE = COMPORTEMENT DE LA FRACTION D'EJECTION AU REPOS ET A L'EFFORT CHEZ DES MALADES AVEC INFARCTUS DU MYOCARDE AVANT ET APRES QUATRE SEMAINES D'ENTRAINEMENT. COMPARAISON A UN GROUPE DE CONTROLEGRODZINSKI E; KREUTZ F; BLUEMCHEN G et al.1983; ZEITSCHRIFT FUER KARDIOLOGIE; ISSN 0300-5860; DEU; DA. 1983; VOL. 72; NO 2; PP. 105-118; ABS. ENG; BIBL. 28 REF.Article

Novel bispecific immunoprobe for rapid and sensitive detection of prostate-specific antigenKREUTZ, F. T; SURESH, M. R.Clinical chemistry (Baltimore, Md.). 1997, Vol 43, Num 4, pp 649-656, issn 0009-9147Article

Efficient bispecific monoclonal antibody purification using gradient thiophilic affinity chromatographyKREUTZ, F. T; WISHART, D. S; SURESH, M. R et al.Journal of chromatography. B, Biomedical sciences and applications. 1998, Vol 714, Num 2, pp 161-170, issn 1387-2273Article

Mimetic ligand-based affinity purification of immune complexes and immunoconjugatesDANZHU XU; LEVEUGLE, B; KREUTZ, F. T et al.Journal of chromatography. B, Biomedical sciences and applications. 1998, Vol 706, Num 2, pp 217-229, issn 1387-2273Article

Considérations chronobiologiques pour la prise en charge des tumeurs de la tête et du cou chez l'homme = Chronobiological considerations for the management of human head and neck cancerFOCAN, C; FOCAN-HENRARD, D; KREUTZ, F et al.Pathologie et biologie. 2003, Vol 51, Num 4, pp 201-203, issn 0369-8114, 3 p.Article

Étude randomisée évaluant la chronotolérance d'une association de 5-fluorouracile, acide folinique et carboplatine chez des patients porteurs d'un cancer pulmonaire non à petites cellules (CPNPC) = Randomised study to evaluate the chronotolerance of a combination infusional chemotherapy with 5-fluorouracil, folinic acid and carboplatin in non small cell lung cancer (NSCLC) patientsFOCAN, C; KREUTZ, F; MOENECLAYE, N et al.Pathologie et biologie. 2003, Vol 51, Num 4, pp 204-205, issn 0369-8114, 2 p.Article

Chronotherapy with 5-fluorouracil, folinic acid and carboplatin for metastatic colorectal cancer; an interesting therapeutic index in a phase II trialFOCAN, C; KREUTZ, F; FOCAN-HENRARD, D et al.European journal of cancer (1990). 2000, Vol 36, Num 3, pp 341-347, issn 0959-8049Article

A new method to generate quadromas by electrofusion and facs sortingKREUTZ, F. T; XU, D. Z; SURESH, M. R et al.Hybridoma. 1998, Vol 17, Num 3, pp 267-273, issn 0272-457XArticle

Production of highly pure monoclonal antibodies without purification using a hollow fiber bioreactorKREUTZ, F. T; JAFARIN, A; BIGGS, D. F et al.Hybridoma. 1997, Vol 16, Num 5, pp 485-486, issn 0272-457XArticle

Production of murine/guinea pig and rat/guinea pig heterohybridomasJAMES, D. E; KREUTZ, F. T; BIGGS, D. F et al.Hybridoma. 1996, Vol 15, Num 5, pp 387-389, issn 0272-457XArticle

QU'ATTENDRE DE LA CHIMIOTHÉRAPIE DANS LE CANCER DE L'ESTOMAC EN 2008 ? = CHEMOTHERAPY FOR HUMAN GASTRIC CANCER : A REVIEWDEMOLIN, G; FOCAN, C; PLOMTEUX, O et al.RMLG. Revue médicale de Liège. 2008, Vol 63, Num 9, issn 0370-629X, 532-541 [10 p.]Article

Intérêt de la chronothérapie dans le traitement pluridisciplinaire des cancers de l'œsophage et de l'estomac = Interest of chronotherapy in multidisciplinary management of œsophageal and gastric cancersFOCAN, C; KREUTZ, F; LONGREE, L et al.Pathologie et biologie. 2007, Vol 55, Num 3-4, pp 181-185, issn 0369-8114, 5 p.Conference Paper

Epitope mapping of prostate-specific antigen with monoclonal antibodiesJETTE, D. C; KREUTZ, F. T; MALCOLM, B. A et al.Clinical chemistry (Baltimore, Md.). 1996, Vol 42, Num 12, pp 1961-1969, issn 0009-9147Article

Étude de faisabilité (Phase I-II) d'une quadruple combinaison associant le 5-fluorouracile, l'acide folinique et le carboplatine à de l'irinotecan administrés en infusion chronomodulée pour le traitement du cancer colorectal avancé = Feasibility survey (Phase I-II) of a four drugs combination (5-fluorouracil, folinic acid, carboplatin and irinotecan) delivered using a chronomodulated infusion in the treatment of advanced colorectal cancerFOCAN, C; KREUTZ, F; GRAAS, M. P et al.Pathologie et biologie. 2005, Vol 53, Num 5, pp 277-280, issn 0369-8114, 4 p.Article

Chronothérapie associant le 5-fluorouracile, l'acide folinique, et le carboplatine en première ligne thérapeutique dans le cancer colorectal métastatique. Une étude de phase 2 = Chronotherapy combining 5-fluorouracil, folinic acid and carboplatin as first line treatment in metastatic colorectal cancer. A phase 2 studyFOCAN, C; KREUTZ, F; DELFORGE, M et al.Pathologie et biologie. 2005, Vol 53, Num 5, pp 273-276, issn 0369-8114, 4 p.Article

Chimiothérapie adjuvante pour le cancer du colon de stades Dukes B2 et C comportant du 5-fluorouracile et de l'acide folinique, avec ou sans carboplatine. Faisabilité et comparaison d'une administration standard à une administration chronomodulée = Adjuvant chemotherapy for Dukes B2 and C colon cancer combining 5-fluorouracil and folinic acid with or without carboplatin. Feasibility and comparison between standard and chronomodulated deliveriesFOCAN, C; BURY, J; MATUS, G et al.Pathologie et biologie. 2005, Vol 53, Num 5, pp 281-284, issn 0369-8114, 4 p.Article

  • Page / 1